Method for determination of concentration of 5, 6-dihydro-7,8-dimethyl-4,5-dioxy-4-H-pyranoquinoline-2-carboxylic acid in plasma
A pyranquinoline and dimethyl technology, which is applied in the field of drug analysis, can solve the problem that the determination method is not reported in literature and the like, and achieve the effects of simple pretreatment method, high sensitivity and rapid method.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0027] Example 1: Determination of the concentration of MY-1250 in human plasma.
[0028] 1. Experimental materials and instruments
[0029] MY-1250 reference substance: provided by Henan Furentang Pharmaceutical Co., Ltd., batch number: 20140501D; levetiracetam reference substance: provided by Zhejiang Huahai Pharmaceutical Co., Ltd., batch number: 201308-2; test water: ultrapure water ; Methanol: Chromatographic Pure (Merck Company); Ammonia, Ammonium Acetate: Analytical Pure (Sinopharm Chemical Reagent Co., Ltd.); Hydrochloric acid: Analytical Pure (Shanghai Lingfeng Chemical Reagent Co., Ltd.).
[0030] API 4000 LC / MS / MS combination instrument (Applied Biosystems, USA), Chromatography Workstation: Analyst 1.6; Mettler XS 105DU Electronic Balance (Mettler, Switzerland); Eppendorf Centrifuge 5424R High Speed Low Temperature Centrifuge (Eppendorf, Germany ); KDC-2042 low-speed refrigerated centrifuge (Anhui Zhongke Zhongjia Scientific Instrument Co., Ltd.); Millipore Drict-Q5 ult...
Example Embodiment
[0052] Example 2: Determination of the concentration of MY-1250 in human plasma
[0053] With reference to Example 1, 5 healthy female subjects took 150 mg of Repilast tablets on an empty stomach, and took it with 250 mL of warm water; 4 hours after the administration, 3 mL of peripheral venous blood was collected, injected into a heparin tube, and centrifuged (4000r·min -1 , 5min), draw 600μL of the subject’s plasma sample, add 12μL of hydrochloric acid solution (5mol·L -1 ), vortex and mix, prepare plasma. The treatment and determination conditions of the medicated plasma samples were the same. As a result, the levels of MY-1250 in the plasma of 5 healthy female subjects who took 150 mg of Repikast tablets on an empty stomach for 4 hours were 50.24, 52.71, 41.2, 26.12, 43.45 ng·mL, respectively -1 .
Example Embodiment
[0054] Example 3: Determination of the concentration of MY-1250 in human plasma
[0055] With reference to Example 1, 5 healthy male subjects took 50 mg of Repilast granules per bag × 3 bags on an empty stomach, and dispense with 250 mL warm water; 2 hours after the administration, 3 mL of peripheral venous blood was collected, injected into a heparin tube, and centrifuged (4000r ·Min -1 , 5min), draw 600μL of the subject’s plasma sample, add 12μL of hydrochloric acid solution (5mol·L -1 ), vortex and mix, prepare plasma. The treatment and determination conditions of the medicated plasma samples were the same. The results showed that the levels of MY-1250 in the plasma of 5 healthy male subjects who took 150 mg of Repikast Granules on an empty stomach were 49.26, 107.6, 56.76, 100.7, and 124.5 ng·mL, respectively. -1 .
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap